Study of the effects of ocular hypotensive drugs on number of neurons in the retinal ganglion layer in a rat experimental glaucoma

被引:6
作者
Villena, Alicia [1 ]
Diaz, Flopentina [1 ]
Vidal, Lourdes [1 ]
Moreno, Mercedes [2 ]
Gapcia-Campos, Jose [2 ]
Perez De Vargas, Ignacio [1 ]
机构
[1] Univ Malaga, Sch Med, Dept Histol & Pathol, E-29071 Malaga, Spain
[2] Univ Malaga, Sch Med, Dept Ophthalmol, E-29071 Malaga, Spain
关键词
Brimonidine; Experimental glaucoma; Latanoprost; Number of neurons; Retinal ganglion layer; Timolol; NITRIC-OXIDE SYNTHASE; OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; INTRAOCULAR-PRESSURE; CELL-DEATH; IN-VIVO; LATANOPROST; MODEL; BRIMONIDINE; DAMAGE;
D O I
10.1177/112067210901900611
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. We investigated the effects of antiglaucomatous drugs on neurons in the retinal ganglion layer (RGL) in an experimental model of elevated intraocular pressure (IOP). METHODS. Three episcleral veins of rats with normal IOP were cauterized. Three months later we examined the effects on the number of neurons in the RGL as well as in rats submitted to treatment with timolol, latanoprost, or brimonidine. The IOP was measured using a calibrated Tono-Pen XL tonometer before and immediately after cauterization and every 2 weeks for the following 3 months as well as immediately before perfusion. RESULTS. The IOP was 14.85 +/- 0.65 mmHg in the control group, whereas it was 1.25-fold higher (33.5 +/- 1.06 mmHg) in the experimental group. After treatment, the IOP returned to baseline levels. The mean number of neurons per mm(2) in the RGL was 33% lower in the experimental group (283 +/- 10 cells/mm(2)) compared with the control group (423 +/- 11 cells/mm(2)). In the groups treated with timolol, latanoprost, or brimonidine, the neuronal loss was less (331 +/- 10, 360 +/- 15, and 333 +/- 3 cells/mm(2), respectively), although values did not return to baseline levels. CONCLUSIONS. This experimental model provokes an immediate, constant, and prolonged increase in IOP and the application of hypotensive agents affords a certain degree of protection to neurons in the RGL. (Eur J Ophthalmol 2009; 19: 963-70)
引用
收藏
页码:963 / 970
页数:8
相关论文
共 44 条
[21]  
Levkovitch-Verbin H, 2002, INVEST OPHTH VIS SCI, V43, P402
[22]   Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia [J].
McCullough, L ;
Wu, LJ ;
Haughey, N ;
Liang, XB ;
Hand, T ;
Wang, Q ;
Breyer, RM ;
Andreasson, K .
JOURNAL OF NEUROSCIENCE, 2004, 24 (01) :257-268
[23]  
Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451
[24]   A rat model of chronic pressure-induced optic nerve damage [J].
Morrison, JC ;
Moore, CG ;
Deppmeier, LMH ;
Gold, BG ;
Meshul, CK ;
Johnson, EC .
EXPERIMENTAL EYE RESEARCH, 1997, 64 (01) :85-96
[25]  
Morrison JC, 1999, INVEST OPHTH VIS SCI, V40, P1702
[26]   Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma [J].
Neufeld, AH .
BRAIN RESEARCH BULLETIN, 2004, 62 (06) :455-459
[27]   Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension [J].
Orzalesi, N ;
Rossetti, L ;
Bottoli, A ;
Fogagnolo, P .
OPHTHALMOLOGY, 2006, 113 (02) :239-246
[28]   INHIBITION OF CAMP PRODUCTION BY ALPHA-2-ADRENOCEPTOR STIMULATION IN RABBIT RETINA [J].
OSBORNE, NN .
BRAIN RESEARCH, 1991, 553 (01) :84-88
[29]   Acute effects of glaucoma medications on rat intraocular pressure [J].
Pang, IH ;
Wang, WH ;
Clark, AF .
EXPERIMENTAL EYE RESEARCH, 2005, 80 (02) :207-214
[30]  
Raymond ID, 2008, MOL VIS, V14, P1559